MEDS vs. COSM, BIMI, OBSV, AQB, CYCN, GRAY, OSA, TRVN, VAXX, and BNOX
Should you be buying TRxADE HEALTH stock or one of its competitors? The main competitors of TRxADE HEALTH include Cosmos Health (COSM), BIMI (BIMI), ObsEva (OBSV), AquaBounty Technologies (AQB), Cyclerion Therapeutics (CYCN), Graybug Vision (GRAY), ProSomnus (OSA), Trevena (TRVN), Vaxxinity (VAXX), and Bionomics (BNOX). These companies are all part of the "medical" sector.
Cosmos Health (NASDAQ:COSM) and TRxADE HEALTH (NASDAQ:MEDS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.
In the previous week, Cosmos Health had 3 more articles in the media than TRxADE HEALTH. MarketBeat recorded 4 mentions for Cosmos Health and 1 mentions for TRxADE HEALTH. Cosmos Health's average media sentiment score of 0.70 beat TRxADE HEALTH's score of 0.22 indicating that TRxADE HEALTH is being referred to more favorably in the news media.
Cosmos Health has higher revenue and earnings than TRxADE HEALTH.
Cosmos Health has a net margin of -31.48% compared to Cosmos Health's net margin of -215.72%. TRxADE HEALTH's return on equity of -28.54% beat Cosmos Health's return on equity.
Cosmos Health has a beta of 5.84, suggesting that its share price is 484% more volatile than the S&P 500. Comparatively, TRxADE HEALTH has a beta of 2.14, suggesting that its share price is 114% more volatile than the S&P 500.
12.6% of Cosmos Health shares are held by institutional investors. Comparatively, 5.7% of TRxADE HEALTH shares are held by institutional investors. 18.7% of Cosmos Health shares are held by company insiders. Comparatively, 48.4% of TRxADE HEALTH shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Cosmos Health received 20 more outperform votes than TRxADE HEALTH when rated by MarketBeat users. Likewise, 70.69% of users gave Cosmos Health an outperform vote while only 52.50% of users gave TRxADE HEALTH an outperform vote.
Summary
Cosmos Health beats TRxADE HEALTH on 11 of the 14 factors compared between the two stocks.
Get TRxADE HEALTH News Delivered to You Automatically
Sign up to receive the latest news and ratings for MEDS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MEDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
TRxADE HEALTH Competitors List
Related Companies and Tools
